Herbalife Stock Price, News & Analysis

Herbalife (NYSE: HLF) announced that CEO Stephan Gratziani and CFO John DeSimone will participate in a fireside chat at the BofA Securities Leveraged Finance Conference on Tuesday, December 2, 2025 at 8:10 a.m. ET (5:10 a.m. PT).

A live webcast link will be available under the Investor Relations section of Herbalife's website at https://ir.herbalife.com/. A replay will be available on the same site following the event and will remain accessible for six months.

Herbalife (NYSE: HLF) reported Q3 2025 results with net sales of $1.3 billion, up 2.7% year‑over‑year (3.2% on a constant currency basis) and adjusted EBITDA of $163.0 million, which exceeded guidance. North America returned to growth with net sales up 1.0%—the region's first quarterly gain since Q2 2021. Diluted EPS was $0.42 and adjusted diluted EPS was $0.50. Net cash from operations was $138.8 million for the quarter and the company repaid $147.3 million of 2025 Notes, lowering total leverage to 2.8x at September 30, 2025.

Full‑year 2025 guidance ranges were tightened for net sales, adjusted EBITDA and capex, and Pro2col beta expansion and HL/Skin launch were highlighted as commercial developments.

Herbalife (NYSE: HLF) received the Direct Selling Association’s 2025 Vision for Tomorrow Award for its Casa Herbalife Program, the flagship initiative of the Herbalife Family Foundation (HFF).

The Casa Herbalife Program has supported more than 170 nonprofit partners across 62 countries, reaching over 200,000 children per year since 1998. HFF has contributed over $60 million to nonprofits since 1994. The award recognizes long-term community impact in nutrition, education, and social responsibility.

Herbalife (NYSE: HLF) opened a new Center of Excellence — Quality Control and Research & Development Labs in Torrance, California on October 27, 2025, representing an approximate $7 million investment. The facility combines R&D, sensory science, and quality control with advanced analytics including HPLC, LC-MS/MS, GC, ICP-MS, and DNA testing to verify ingredient identity, purity, and potency.

The Torrance lab joins two U.S. sites and a global network of ISO 17025-accredited labs, houses >40 scientists, supports clinical validation and AI-driven discovery, and earned My Green Lab Green Level certification.

Herbalife (NYSE: HLF) was named to Forbes’ inaugural America’s Best Brands for Value list on October 13, 2025, ranking among the top 9% of more than 3,500 brands evaluated.

The Forbes list used >3.8 million consumer ratings across 3,500 brands and placed the top 300 brands on the list; companies pay no fee to be considered. Herbalife highlighted its focus on product quality, affordability, distributor access, and community, and noted ~8,600 employees and a global network of ~2.1 million independent distributors. The company also referenced prior recognition on the U.S. News & World Report 2025–2026 Best Companies to Work For list.

Herbalife (NYSE:HLF), a health and wellness company, has scheduled its third quarter 2025 financial results announcement for November 5, 2025, after NYSE market close.

The company will host an audio webcast and conference call at 5:30 p.m. ET (2:30 p.m. PT) on the same day, where senior management will discuss the financial results. Participants can access the webcast directly or join via conference call by registering for dial-in information. The earnings release, supplemental materials, and a 12-month replay will be available on Herbalife's investor relations website.

Herbalife (NYSE:HLF), a health and wellness company, announced that CEO Stephan Gratziani and CFO John DeSimone will participate in a fireside chat at the Barclays Global Consumer Staples Conference on September 2, 2025 at 4:30 p.m. ET.

The presentation will be accessible through a live webcast on Herbalife's investor relations website, with a replay available for six months after the event.

Herbalife (NYSE:HLF) reported Q2 2025 financial results with net sales of $1.3 billion, down 1.7% year-over-year but near guidance midpoint. The company's adjusted EBITDA reached $173.6 million, exceeding guidance, while adjusted diluted EPS was $0.59.

Key developments include the launch of MultiBurn™, a new weight-loss supplement, and the beta release of the Pro2col™ digital platform, with over 7,000 distributors joining the early access phase. The company has raised its full-year 2025 guidance for net sales and adjusted EBITDA, now projecting net sales growth between -1.0% to +3.0% YoY and adjusted EBITDA of $640-660 million.

Herbalife (NYSE:HLF) has launched MultiBurn™, a new science-backed weight loss supplement targeting metabolic health. The product features three key botanical ingredients: Morosil™ from Moro blood oranges for weight and circumference reduction, Metabolaid® (hibiscus and lemon verbena) for fat reduction and satiety, and Capsifen™ (red chili pepper and fenugreek) for energy expenditure.

The supplement is designed for daily use with three capsules taken with breakfast or lunch. MultiBurn™ is vegan, gluten-free, and made without synthetic colors or dyes. The product is currently available in the United States, with a planned launch in Puerto Rico in September 2025.